ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 2604

$720K Total Retail Price of All Prescriptions

Rank: 70 out of 2604

282 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 282 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,332 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
OMEPRAZOLE 494 309 1 5
SIMVASTATIN 429 308 2 2
LEVOTHYROXINE SODIUM 391 283 3 4
RISPERIDONE 390 185 4 65
LISINOPRIL 385 264 5 3
METOPROLOL TARTRATE 352 242 6 9
AMLODIPINE BESYLATE 348 269 7 6
CITALOPRAM HBR 323 254 8 18
FUROSEMIDE 304 224 9 8
QUETIAPINE FUMARATE 293 131 10 66
BENZTROPINE MESYLATE 263 57 R 11 189
OLANZAPINE 232 93 12 115
SERTRALINE HCL 219 146 13 23
DONEPEZIL HCL 216 206 14 28
TRAZODONE HCL 209 141 15 46
DIVALPROEX SODIUM 205 40 16 81
LACTULOSE 166 66 17 108
CLOZAPINE 150 69 18 248
MIRTAZAPINE 143 96 19 52
HALOPERIDOL 133 21 20 218
WARFARIN SODIUM 133 113 20 13
VALPROIC ACID 130 29 22 229
METFORMIN HCL 128 46 23 7
CARBIDOPA-LEVODOPA 124 124 24 97
LEVETIRACETAM 124 25 24 96
IBUPROFEN 123 68 26 32
HYDROCHLOROTHIAZIDE 121 71 27 10
NAMENDA 114 114 28 37
SEROQUEL 112 43 29 149
PANTOPRAZOLE SODIUM 109 66 30 64
SPIRIVA 107 66 31 45
GABAPENTIN 107 103 31 12
ISOSORBIDE MONONITRATE ER 104 79 33 38
ATENOLOL 98 75 34 11
NITROFURANTOIN MONO-MACRO 94 88 35 299
RANITIDINE HCL 86 64 36 25
HYDROCODONE-ACETAMINOPHEN 85 70 S3 37 1
OXYBUTYNIN CHLORIDE 82 46 38 92
TAMSULOSIN HCL 81 48 39 30
PROAIR HFA 80 51 40 27
TRAMADOL HCL 79 45 41 15
FAMOTIDINE 71 39 42 68
CIPROFLOXACIN HCL 70 61 43 59
ALENDRONATE SODIUM 68 68 44 29
DIVALPROEX SODIUM ER 67 0 45 212
LEVOFLOXACIN 62 56 46 113
LAMOTRIGINE 58 16 47 185
ADVAIR DISKUS 56 30 48 41
CARVEDILOL 55 33 49 26
MEGESTROL ACETATE 55 42 R 49 249
POTASSIUM CHLORIDE 54 48 51 16
FLUPHENAZINE HCL 53 22 52 483
DILTIAZEM 24HR ER 53 43 52 172
ATORVASTATIN CALCIUM 53 27 52 19
CLOPIDOGREL 52 51 55 39
GLYBURIDE 52 13 R 55 83
TRAVATAN Z 51 25 57 228
SINGULAIR 50 29 58 120
LOSARTAN POTASSIUM 50 50 58 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.